Pancreatic Cancer Research

ResearcherUniversidad de GranadaActive in the last 2 years

Francisco Quiñonero

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9087-8161; OpenAlex author ID A5010451128. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 9

  1. Preclinical evidence for cytokine-based immunotherapy in pancreatic cancer treatment: A systematic review. Co-author DOI 10.1016/j.ijbiomac.2026.153486↗
  2. Nanoparticles Bounded to Interfering RNAs as a Therapy for Pancreatic Cancer: A Systematic Review. First author DOI 10.1002/wnan.2013↗
  3. Fungi-Derived Bioactive Compounds as Potential Therapeutic Agents for Pancreatic Cancer: A Systematic Review. Co-author DOI 10.3390/microorganisms12081527↗
  4. Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer. Co-author DOI 10.2147/ijn.s415631↗
  5. PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine. Co-author DOI 10.1016/j.biopha.2022.113669↗
  6. Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress. First author DOI 10.3390/cancers13092058↗
  7. The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study. Co-author DOI 10.3390/cancers13133169↗
  8. Nanomedicine in Pancreatic Cancer: A New Hope for Treatment. Co-author DOI 10.2174/1389450121666200703195229↗
  9. The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview. Co-author DOI 10.20892/j.issn.2095-3941.2019.0252↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Consolación Melguizo · 9 shared papers, 2019–2026 · strength 1.77
  2. Jose Carlos Prados · 9 shared papers, 2019–2026 · strength 1.77
  3. Raúl Ortíz · 6 shared papers, 2021–2024 · strength 1.18
  4. Gloria Perazzoli · 5 shared papers, 2019–2023 · strength 0.69
  5. Cristina Jiménez‐Luna · 3 shared papers, 2019–2023 · strength 0.44
  6. Jorge Rodríguez-Criado · 1 shared paper, 2026 · strength 0.39
  7. Kevin Doello · 3 shared papers, 2019–2021 · strength 0.35
  8. Patricia Lara · 1 shared paper, 2024 · strength 0.28
  9. Pablo Redruello Guerrero · 1 shared paper, 2020 · strength 0.11
  10. Antonio Jesús Láinez Ramos‐Bossini · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.